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The ARVmobile v1.0 is a multiplatform mobile personal health monitor (PHM) application for ambulatory blood pressure (ABP)
monitoring that has the potential to aid in the acquisition and analysis of detailed profile of ABP and heart rate (HR), improve the
early detection and intervention of hypertension, and detect potential abnormal BP and HR levels for timely medical feedback. The
PHM system consisted of ABP sensor to detect BP and HR signals and smartphone as receiver to collect the transmitted digital data
and process them to provide immediate personalized information to the user. Android and Blackberry platforms were developed
to detect and alert of potential abnormal values, offer friendly graphical user interface for elderly people, and provide feedback to
professional healthcare providers via e-mail. ABP data were obtained from twenty-one healthy individuals (>51 years) to test the
utility of the PHM application. The ARVmobile v1.0 was able to reliably receive and process the ABP readings from the volunteers.
The preliminary results demonstrate that the ARVmobile 1.0 application could be used to perform a detailed profile of ABP and HR
in an ordinary daily life environment, bedsides of estimating potential diagnostic thresholds of abnormal BP variability measured
as average real variability.

1. Introduction
Chronic noncommunicable diseases (NCDs), such as heart
disease, stroke, cancer, chronic respiratory conditions, and
diabetes, are the leading cause of mortality in the world,
accounting for 63% of all deaths [1]. The leading cause of
NCD deaths in 2008 was cardiovascular diseases (CVDs),
accounting for 17 million deaths, nearly 30% of global
mortality [2]. Thirteen percent of global deaths are attributed
to hypertension, the leading risk factor for mortality [2]; the
prevalence of hypertension in the global adult population was
estimated to be 26% in 2000 and was predicted to increase by
about 60% by 2025, to a total of 1.5 billion [3].

Technological innovations that improve prevention and
control of CVDs are desperately needed. In this sense, recent
studies using the average real variability (ARV) index [4]
reported a significant association between high readingto-reading blood pressure (BP) variability (BPV) and cardiovascular events [4–8]. The ARV is a novel index that
has proven to be a more accurate method to assess BPV
than the commonly used standard deviation (SD) [4–6, 9,
10]. BPV is a multifaceted phenomenon, influenced by the
interaction between external emotional stimuli, such as stress
and anxiety, and internal cardiovascular mechanisms that can
vary from heartbeat to heartbeat. The complexity of BPV
makes analysis difficult, and its independent contribution as
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predictor of cardiovascular outcomes is not yet completely
clear [11]. Nevertheless, monitoring of BPV in daily life
might provide a means to control hypertension, ultimately,
preventing CVDs.
Currently available ambulatory blood pressure (ABP)
monitors are portable, fully automatic devices that can record
BP for 24 hours or longer, while subjects go about their
normal daily activities [12]. This technique provides a better
estimate of risk in an individual subject than traditional
clinical methods, because it (i) removes variability among
individual observers, (ii) avoids the “white coat” effect (the
transient, but variable elevation of BP in a medical environment [13]) and “masked hypertension” (normotensive
by clinical measurement, but hypertensive by ambulatory
measurement [14]), (iii) includes the inherent variability
of systolic and diastolic BP (SBP and DBP) [15], and (iv)
provides information on changes in BP, that is, circadian components. A circadian BP profile with a reduced decrease in
nighttime BP level (nondipper status) can indicate increased
cardiovascular risk [16–18]. However, the wider use of ABP
monitoring, although justified, is limited by its availability
and cost. Patients referred to use this technology tend to
pay approximately $40 to $70 (USD) per test, depending
on the volume of tests performed (i.e., minimum cost per
test could only be achieved by a high-volume testing center)
[19]. Furthermore, there is currently no experimental or
commercial ABP device that estimates BPV through the ARV
index.
This paper presents a mobile personal health monitor
(PHM) application for ABP monitoring, with the goal of
improving health care through early diagnosis of abnormal
BP and heart rate (HR) levels, better hypertension control,
electronic health registry of individuals, and data for clinical
prognosis of CVDs. The paper includes an overview of
PHM systems; describes the advantages and limitations of
such a mobile health initiative; describes our mobile PHM
application in detail, including design considerations and
graphic user interface (GUI); discusses the specific context,
strengths, and limitations of our approach; proposes future
improvements.

2. Mobile Personal Health Monitor
Mobile PHM systems provide personalized, intelligent, reliable, noninvasive, real-time, and pervasive health monitoring
[20, 21]. They are part of a body area network (BAN),
integrated by a mobile base unit (MBU), with a set of wearable
wireless sensors with on-board processing, wireless data
transfer, and energy storage capability (Figure 1). The sensors
are attached to the user’s body; the collected data may be
processed locally within the body sensors and/or remotely
via wireless transmission to the MBU. The MBU analyzes
the data in real-time and provides immediate feedback and
personalized information to the user. The analyzed data
can also be sent to professional healthcare providers for
medical feedback and to support clinical decisions. Mobile
PHM systems offer a set of functions that give them global
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appeal; however, some features might limit their usability and
acceptance.
2.1. Pervasive Monitoring. The goal of pervasive monitoring
in mobile PHM systems is to provide healthcare services to
anyone at any time, overcoming the constraints of place, time,
and character [22]. Data processing should be incorporated in
the subject’s environment in such a way that the interaction
between the user and the MBU becomes natural, and the user
can obtain personalized information in a totally transparent
form.
2.2. Integrated Multisensing Platform. Mobile PHM systems
can support biosensors that monitor vital signs (e.g., HR,
BP, and blood glucose), environmental conditions (temperature, humidity, and light), and location, integrated by a
multisensing platform. Light weight and portability allow
long-term, unobtrusive, noninvasive, and ambulatory health
monitoring.
2.3. Real-Time Data Analysis. The mobile PHM software of
the MBU stores and analyzes the data received from the
sensors in real-time, providing instantaneous feedback to the
user. PHM systems could alert the user of abnormal events or
abrupt changes in near real time, for example, by vibration,
loud sound, and/or flashing screen messages.
2.4. Personalized Health Care. Users can configure mobile
PHM systems to their specific healthcare needs and preferences, depending on the user’s biological profile, as well as
the clinical application [23]. Diagnostic thresholds of the risk
factor under study could be defined by the user’s age, gender,
and ethnicity.
2.5. Electronic Data Collection. Mobile PHM systems allow
rapid digitization of recorded data, greatly improving quality
and efficiency compared to traditional data collection processes with subsequent transcription to computer systems
[22]. Continuous monitoring and subsequent transmission
to healthcare providers offer an extensive clinical database
for data mining analysis of potential risk factors and/or
associations among clinical attributes.
2.6. Flexible Communication Protocol. The communication
protocols of a mobile PHM system are extremely flexible,
because local communication within the BAN can use Wi-Fi
[24], Bluetooth [25], or ZigBee [26], and remote communication can be performed via 3G [27] or other available internet
communication.
2.7. Data Security, Confidentiality, and Privacy. Concern
about security, confidentiality, and privacy of user health
data is an important barrier to the use of mobile PHM
systems. Security breaches in data transmission could generate situations where confidential data of a heart patient,
for example, are manipulated by malicious attackers; regular
readings could be altered to indicate a serious problem,
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Figure 1: High-level architecture of mobile personal health monitor system.

and the resulting inaccurate feedback could even cause the
patient to have a heart attack [22]. Alternatively, the data
might be of interest to parties not authorized by the user,
such as insurance companies or employers, and such access
might result in privacy concerns [28]. Thus, policymakers
and program managers must be aware of security issues in
the mobile health domain, so that appropriate policies and
protections can be developed and implemented [29].
2.8. Need for Multiplatform Applications. The development
environments for mobile phones include various systems,
such as Android, BlackBerry, iPhone, and Windows Phone
platforms. Each uses a different software language, and
applications developed for one environment do not operate in
the others [30]. For example, Withings company developed a
mobile system that manually registers self-measurements of
BP through a wired connection between the sensor and the
mobile device, but which only operates in Apple platforms
[31]. At present, mobile phones service providers do not
compete strongly to offer health-related services. However,
expectations of market growth [32–34] could worsen the
scenario, because the pursuit of market leadership might
further fragment the same. Therefore, multiplatform mobile
PHM applications are needed.
2.9. Usability and Acceptance among Elderly. While older
people are less apt to accept novel and unknown technology
than younger people [35], recent studies found that older
adults are motivated to use mobile applications if they are
satisfactorily informed about the resulting benefits [36, 37].
Elderly people should be the primary target population of
mobile PHM for several reasons. First, the global population
is aging [38], and chronic NCDs are associated with advanced
age [39], so that multimorbidity (coexistence of two or more
chronic diseases) is expected to become an increasingly
common problem [40]. Second, many elderly people now
live alone, with no one to help them to record physical
signs like blood pressure [41]. Third, the chances of surviving
a fall, heart attack, or stroke are six times greater if the

elderly get help within an hour [41]. Finally, mobile PHM
systems could provide the elderly with real-time, long-term,
nonintrusive assisted living and care services, tailored to
their personal health condition [41]. However, acceptance of
mobile PHM by older adults is not only based on their health
requirements but also on their perspective of technology.
Since cognitive performance commonly declines with age,
minimizing the complexity of healthcare applications and
user-application interactions could be key to the adoption
of mobile PHM systems by elderly users and should be
considered in their design and development [42]. Therefore,
simplicity and motivation seem to be the key factors for
usability and acceptance of mobile PHM applications by
elderly people.

3. A New Mobile PHM for Ambulatory
Blood Pressure Variability
3.1. Rationale. ARV, a recently tested indicator of readingto-reading BPV [4], has been shown to be significantly
related to cardiovascular outcomes [4–8]. ARV attempts to
correct for the limitations of the commonly used SD, which
accounts only for the dispersion of values around the mean,
and not for the order of the BP readings [4–6, 9, 10]. ARV
is particularly useful for examining effects of intermittent
stress on the cardiovascular system; intermittent BP load on
cardiovascular structures may be as important as tonic BP
load [43]. Although for most outcomes, ARV was found to
be an independent and better predictor of cardiovascular
risk than SD [4–6, 8], no previous study has estimated
ARV using real-time monitoring, because up to this point,
no commercial or experimental real-time device has been
capable of monitoring ABP and determining ARV.
Most current healthcare surveillance technologies and
diagnostic tools are used in clinical environments, providing only a snapshot of disease under conditions different
from the patient’s normal lifestyle. The results could lead
to difficult or even incorrect diagnoses [20]. Personalized
health monitoring in the patient’s own environment could
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Figure 2: The ARVmobile v1.0. for an Android platform.

significantly improve early detection of CVDs. Personal ABP
monitoring would result not only in more accurate diagnosis
hypertension but also more effective monitoring of response
to therapy, thereby aiding a more tailored approach to patient
monitoring.
The ARVmobile v1.0 is a multiplatform, mobile PHM
application for real-time, noninvasive, and long-term ABP
monitoring (Figure 2). The ARVmobile 1.0 could (i) provide
a detailed picture of ABP and heart rate (HR) in a normal
environment, (ii) improve the early detection and intervention of hypertension, (iii) improve treatment of hypertension,
(iv) identify unexpected responses to antihypertensive treatment, and (v) provide data for the estimation of diagnostic
thresholds of abnormal BPV measured as ARV.
3.2. Hardware and Software. The ARVmobile v1.0 was proved
in two smartphones (Figure 3). The Samsung I-9100 Galaxy
S II, which runs Android OS v2.3 on an ARM Cortex-A9
CPU, with a clock rate of 1.2 GHz Dual Core and 1 GB RAM
LPDDR2 [44]. It supports Bluetooth v3.0+HS, Wi-Fi 802.11
a/b/g/n, and USB v2.0; the BlackBerry 9900 Bold that runs
BlackBerry OS v7 on a Qualcomm MSM8655 CPU, with a
clock rate of 1.2 GHz and 768 MB RAM [45]. It supports
Bluetooth 2.1 A2DP/EDR, Wi-Fi 802.11 b/g/n, and USB v2.0.
The ARVmobile v1.0 used an ABPM50 [46] to measure BP in
millimeters of mercury (mmHg) and HR in beats per minute
(bpm). The ABPM50 is an ABP monitor device of low cost
that continuously and noninvasively monitors BP level by the
oscillometric method [47] and uses Bluetooth for wireless
communication. Its sensor has an accuracy of ±3 mmHg and
meets ANSI/AAMI SP10-1992 standards [48]. The ABPM50
has a DC power of 3 V (2 AA 1.5V alkali batteries), weighs
∼1 kg, and can record more than 600 measurements in 48
hours, in programmable time intervals of 15, 30, 60, 120, or
240 minutes.
The ARVmobile 1.0 for Android was developed in
Android 2.2 Froyo [49] with the Eclipse Integrated Development Environment (IDE) 3.7 for Java developers [50] and
the Android Development Tool plugin 20.0.2 [51], on MAC
OS 10.7 [52], Ubuntu OS 11.10 [53], and Windows OS 7
[54]. The ARVmobile 1.0 for BlackBerry was developed in
BlackBerry Java application development 5.0 [55], with the
Eclipse IDE 3.6.5 for Java developers [50] and the Blackberry
Java plugin 1.5 [56], only on Windows OS 7. Both applications
were developed with Java Class Thread [57] as the thread

Figure 3: Android and Blackberry smartphones and the ABPM50
device.

of program execution. The Java Virtual Machine allows an
application to have multiple threads of execution running
concurrently, so that the smartphone maintains normal operations while receiving real-time BP and HR measurements
from the sensor.
3.3. Communication between ABPM50 and Smartphone.
Wireless communication between the ABPM50 and smartphone is via Bluetooth. The connection is initiated by setting
the smartphone on discovery mode, allowing it to detect
the ABPM50 and establish Bluetooth pairing [25]. When
the devices detect each other, the smartphone prompts the
ABPM50 passkey, sends it to the ABPM50, and validates
that the same passkey has been sent and received. If the
passkey is verified, secure Bluetooth pairing occurs, and data
can be exchanged. To save smartphone energy, the smartphone remembers the Bluetooth pairing and is automatically
switched to hidden mode after receiving monitoring readings
and changed to discovery mode again before the ABPM50
sends new readings.
The smartphone must know the Media Access Control
address of the ABPM50 that uniquely identifies each device of
a BAN. Radio frequency communication [25] must be used as
transport protocol to share the communication channel with
other Bluetooth devices.
3.4. Setting Parameters for the ARVmobile 1.0. Before using
the ARVmobile 1.0 to monitor ABP and HR, threshold
settings for daytime and nighttime periods must be set
correspond to the waking and sleeping patterns of the user
(Figure 4). The time intervals between two consecutive
readings, which can differ for daytime and nighttime periods,
must also be set. According to current clinical guidelines
[58, 59], readings should be taken at intervals of 30 minutes
or less, and the daytime interval must be smaller than or
equal to the nighttime interval. In the current, experimental
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Table 1: Measurement range of different ABP monitors.
Manufacturer
Model
SBP range DBP range HR range
CONTEC MS ABPM50
10–270
10–270
40–240
SunTech
Oscar 2
25–260
25–260
40–200
Well Alynch
6100S
60–250
25–200
40–200
SpaceLabs
90207
60–260
30–200
40–180
A&D Medical TM-2430-DP 60–280
40–160
30–200

(Figure 6) were based on those used by the SpaceLabs 90207,
which is considered to be an accurate ABP monitor [63–65].

Figure 4: ABP thresholds set on the Blackberry graphic user
interface.

3.6. Estimating ARV with the ARVmobile. The ARVmobile 1.0
computes weighted averages of BP and HR, based on the time
intervals between consecutive valid measurements, for 24hour, daytime, and nighttime periods [6]. Weighted averages
provide more accurate estimates than standard averages,
which assume that all measurements contribute equally [66].
ARV for a specified period is calculated using
ARV =

version of the ARVmobile, the threshold settings for daytime
and nighttime periods of the ARVmobile and ABPM50 must
match (Figure 5), so that the smartphone can determine when
to enable (receiving readings) and disable (saving energy)
the Bluetooth. Although the ARVmobile was designed to
use a sensor without on-board processing and to establish
a master-slave relationship controlled by the smartphone,
current market restrictions did not allow this type of implementation.
3.5. Accuracy of the ARVmobile Monitoring. The goal of
the ARVmobile 1.0 and other medical diagnostic devices is
to maximize diagnosis accuracy by providing a sufficient
amount of accurate data. In ABP monitoring, movement and
physical activity often result in invalid ABP readings [60], and
recordings can also fail for technical reasons (e.g., improper
cuff fitting and auscultatory gap) or patient conditions (e.g.,
cardiac arrhythmia, rapid pressure changes, severe shock,
and HR extremes). A recent review of 25 papers on ABP
monitoring found that at least 10% of readings are invalid
[61]. Another publication concluded that ABP recordings
are successful when at least 85% of readings are suitable for
analysis [62]. Current guidelines for management of hypertension indicate that ABP monitoring should be repeated if
the recording has fewer than 70% of the expected number
of valid values [58]. Thus, there is no specific minimum
percentage of valid measurements used to determine the
accuracy of ABP monitoring, but there is agreement that a
percentage of invalid readings is allowed.
To deal with outlying values, each ABP device has set
ranges of BP, ARV, and HR that determine inclusion or
exclusion of a reading, which cannot be modified by the user.
The ABPM50 has a broader range of operating parameters
than other commercial ABPM devices (Table 1), which
could increase the number of erroneous readings recorded.
Therefore, the measurement thresholds of the ARVmobile 1.0

1 𝑛


∑ 𝑤 × BP − BP𝑘  ,
∑ 𝑤𝑘 𝑘=1 𝑘  𝑘+1

(1)

where 𝑛 is the number of valid BP readings, 𝑘 ranges from 1
to 𝑛, and 𝑤𝑘 is the time interval between BP𝑘 and BP𝑘+1 ; 𝑤𝑛
is the time difference between BP1 and BP𝑛 .
Using weighted averages and ARV to monitor BPV has
several advantages. For example, although the BP recording
in Figure 7(a) is visibly more variable than the recording in
Figure 7(b), the SD values are the same, because SD reflects
only dispersion of values around the mean and not their
temporal distribution [67]. In contrast, ARV computed for
the more variable recording in Figure 7(a) is almost twice that
for the recording in Figure 7(b), providing a more accurate
measure of temporal variability in BP.
All of the BP profiles in Figure 7 have a 50% ambulatory
SBP load (percentage of systolic readings > 140 mmHg).
This ABP parameter improves sensitivity and specificity in
the diagnosis of hypertension [68, 69]. Patients with mild
hypertension who have an ambulatory SBP load >40% should
be strongly considered for antihypertensive therapy [70].
In agreement with this indicator, the weighted average BP
(wAvg) for the profile in Figure 7(a) is 136.1 mmHg, which is
close to the systolic cutoff for normality in most hypertension
guidelines [70], while the standard average BP (Avg) is
125 mmHg, which is between optimal and normal ABP level
[71, 72]. Thus, the use of weighted values provides a more
accurate hypertension diagnosis.
Figures 7(a) and 7(c) present similar BP profiles, but the
record in Figure 7(c) starts with a high SBP and ends with
a lower value, similar to a normal circadian, or “dipper,”
pattern in which BP decreases during sleep and rises sharply
upon awakening [73]. Several studies have confirmed that
high nocturnal BP, as seen in Figure 7(a), predicts a higher
rate of cardiovascular complications [16–18]. This nondipper
status is reflected in the higher wAvg in Figure 7(a), because
as recommended, the ABP device is programmed with
longer nighttime than daytime intervals, resulting in a higher
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Figure 5: Matching daytime and nighttime thresholds and recording intervals on a Blackberry and ABPM50 graphic user interface.

Figure 6: Measurement thresholds set on the Android graphic user
interface.

weighting factors. The dipper pattern is also observed in
Figure 7(d), which has a lower frequency of BP recordings.
In this case, wAvg corrects for discarded readings by using
higher weighting factors, so that wAvg is similar for Figures
7(c) and 7(d). Although Avg for all four profiles is the same,
wAvg computed for Figures 7(c) and 7(d) reflect normal ABP
levels and are lower than wAvg for Figure 7(a). Thus, wAvg
takes into account effects of BP load, noddipper status, and
discarded readings.
3.7. The ARVmobile Feedback. The goals of the ARVmobile
1.0 are to identify abnormal levels of traditional or novel

cardiovascular risk factors and provide timely feedback to
professional healthcare providers. To accomplish these goals,
the ARVmobile 1.0 uses a simple GUI (Figure 8) that is
user-friendly for older patients, allowing them access to
instantaneous feedback and alerting them about abnormal
values that are highlighted in red. The ARVmobile 1.0 also
provides a graphic ABP profile (Figure 9) that can be scrolled
sideways on the screen. The user has the option of sending
ABP results via e-mail to specified third parties, such as family
members, and sends a complete output report in PDF format
to specified healthcare professionals (Figure 10). The report
includes 24-hour, daytime, and nighttime BP and HR levels,
ARV, BP load, pulse pressure (differences between SBP and
DBP [74]), and identification of abnormal APB values outside
of the set thresholds. A graphic presentation of the circadian
pattern (Figure 9) can be integrated into the PDF file or
sent separately in JPGE format. The ARVmobile 1.0 allows
feedback to be forwarded to up to three e-mail addresses and
can be configured to automatically send ABP and HR profiles
at the end of each monitoring period or only after monitoring
periods in which abnormal values are detected. The report
can be sent in Spanish or English (Figure 11).
3.8. The ARVmobile Trial. At the time of writing this paper,
over twenty-one subjects aged higher than 51 (mean age
58.9 ± 6.1 years; 61.9% women) have used the ARVmobile
1.0. Volunteer subjects without history of cardiovascular
disease and hypertension were recruited in the mobile computer laboratory of the Polytechnic University of Sinaloa,
in Mazatlan, Mexico. Recruited participants had reasonable
computer skills and were assertive about using new technologies. Informed consent was obtained from every participant.
Participants were provided of an ABPM50 device and an
Android or Blackberry smartphones and were instructed
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Figure 7: Estimates of average BP (Avg), weighted average BP (wAvg), standard deviation (SD), and average real variability (ARV) for four
different systolic blood pressure (SBP) profiles, recorded at intervals of 15 min. The number of values is lower in (d), due to invalid readings
that were not recorded. In all four cases, Avg = 125 mmHg.

how to use the PHM application and ABP sensor and to
continue with their usual daily activities. The ABPM50 was
programmed to obtain readings at 15 minute intervals during
awake time (06:00–22:59) and at 30 minutes intervals for the
sleeping period (23:00–05:59). The median number of ABP
readings was 70 (5th to 95th percentile, 62–79) with a high
percentage (>75%) of valid readings. To validate the accuracy
of the wireless communication and data processing, BP and
HR readings from each subject recorded in the PHM system
were compared against those captured by the ABP monitor,
without finding inconsistencies between the ABPM50 and
ARVmobile records. A posterior survey indicated that the
majority of the participants found the ARVmobile 1.0 easy
to use and considered the time spent learning how to use
the PHM application reasonable. The preliminary results
demonstrate that the ARVmobile 1.0 application could be
used to perform a detailed profile of ABP and HR in an
ordinary daily life environment.

4. Discussion
The ARVmobile 1.0 is the result of an interdisciplinary effort
in clinical research, data mining analysis, and development
of mobile applications. Development focused on (i) an
innovative mobile PHM application; (ii) support of early

diagnosis and intervention of CVDs, based on cardiovascular
risk factors and pattern recognition [75–78] identified by
clinical studies [4, 79–82]; (iii) novel strategies to improve
adoption by user-friendliness for elderly people.
The inclusion of the capability of calculation of ARV is
a major innovation of the ARVmobile 1.0. Although ARV
has been shown to be an accurate indicator of BPV [4–
6, 9, 10], as well as a significant and independent predictor
of cardiovascular complications, when adjusted for BP level
and other covariates [4–8], its use to date has been primarily
for research, rather than for clinical purposes. However, the
clinical use of BPV via calculation of ARV could improve the
diagnosis and prognosis of hypertension by providing better
information on progressive and end-point organ damage
associated with high BP values. Furthermore, BPV could be
useful in assessing the efficacy of antihypertensive agents [83]
and developing new therapeutic drugs to treat hypertension
[84].
The use of weighted averages (wAvg) to construct BP and
HR profiles is another major innovation of the ARVmobile
1.0, and wAvg takes the sequential order of measurements
into account and, therefore, more accurately represent effects
of intermittent stress on the cardiovascular system. Effects of
intermittent BP load on cardiovascular structures might be as
important as tonic BP load [43], and estimation of ARV and
wAvg incorporates this phenomenon.
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(a)

(b)

Figure 8: The ARVmobile-Blackberry graphic user interface for (a) instantaneous feedback and (b) forwarding an ABP profile to selected
recipients.

Figure 9: The ARVmobile-Blackberry graphic user interface showing a circadian pattern in ABP.

An important goal of the ARVmobile 1.0 is to provide
more effective personal surveillance of elderly hypertensive
patients, resulting in a personally tailored approach to hypertension control. One previous study showed that people
who check their own BP tend to be more conscious of the
importance of taking their medication on a regular basis [85].
The user might notice resistance to antihypertensive drugs or
specific foods and activities that raise their BP, and they can
adjust their lifestyle, accordingly.
Although use of mobile PHMs could improve and support the lives of the elderly, seniors are often viewed as
luddites, reluctant to use modern technology. Thus, development of the ARVmobile 1.0 considered user acceptance and
adoption specifically with respect to elderly populations. The
first barrier is hardware reluctance. However, a recent market
study reported that the 6.2 million working Americans aged
65 and older increased smartphone ownership by 150%

during 2007–2010 [86]. The acceptability and ethical aspects
of body sensors also could be an important consideration
to elderly users. However, widespread use of other personal
technologies, such as the Bluetooth headset and smartphone,
suggests that older people will easily adjust to wearing sensors
for long periods outside of clinical environments [20]. The
ARVmobile 1.0 was purposefully designed to be user-friendly
to elderly patients with reduced vision and manual dexterity.
It has a simplified GUI with a bright screen, large text
and numbers, and simple input buttons with touchscreen
technology, all of which have been proven to be efficient for
older adults [87].
The usability of any application depends on the acquisition of new procedural knowledge for proper operation and
interaction; therefore, simple design makes the application
more usable [88]. This is especially true for older users,
because cognitive performance commonly slows down with
age. The ARVmobile 1.0 has only three interactive menus
(home, settings, and graphical trend). Only the settings menu
contains submenus, and these are usually adjusted only once.
Security mechanisms, such as user identification for access,
were omitted, because users can activate such mechanisms
through the security settings of the smartphone. To assure
privacy, reports forwarded to selected recipients lack personal
identification, which is already associated with the source email address. The ability to operate the ARVmobile 1.0 in
either Spanish or English is another user-friendly feature
(Figure 11).
Perhaps the most important factor in acceptance and
adoption of a mobile PHM system is the user’s motivation,
which depends on their understanding of the magnitude of
the health problem and the benefits of the mobile application.
To motivate potential users of the ARVmobile 1.0, it is
necessary to disseminate information about the importance
of prevention and control of hypertension. Although global
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Date: 09/24/2012
Daytime: 07:00
Daytime interval: 15 min

Duration: 23:42 min
Nighttime: 23:00
Nighttime interval: 30 min

Normal level
24-hour
SBP: 130–90 mmHg
DBP: 80–60 mmHg
SARV: 9.5–6.5 mmHg
DARVD: 7.5–4.5 mmHg
HR: 90–60 bpm

Daytime
SBP: 135–95 mmHg
DBP: 85–65 mmHg
SARV: 10–7 mmHg
DARVD: 7–4 mmHg
HR: 100–70 bpm

Readings: 73 (91.25%)
End: 06:42

Nighttime
SBP: 120–85 mmHg
DBP: 70–55 mmHg
SARV: 9–6 mmHg
DARVD: 7–4 mmHg
HR: 80–50 bpm
Nighttime
DBP
HR
SBP
59
14
14
96.83 ∗ 121.12 ∗ 79.36
∗
∗
12.71
10.02
—
—
41.21
—
35.71
78.57
139
132
88
96
56
37

24 hours
Daytime
DBP
DBP
SBP
HR
SBP
HR
59
14
73
73
73
59
Readings
∗
∗
∗
84.95
136.91
89
74.97
87.64
Weighted average
(mmHg/bpm) ∗130.27
∗
12.37
8.79
—
—
12.12
7.91
(mmHg)
ARV
—
—
46.37
47.59
(mmHg)
Pulse pressure
—
—
54.24
56.16
79.45
74.58
(%)
Blood pressure load
87
162
110
139
162
110
(mmHg/bpm)
Maximum value
(mmHg/bpm)
64
114
67
96
56
37
Minimum value
∗
Ambulatory blood pressure value at least 1 unit outside of normal level.
— Indicates not applicable.
∙ Systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) levels were computed with weighted average, using
as weighting factor the time interval between consecutive valid readings.
∙ Average real variability (ARV) was computed with weighted average of the absolute differences of consecutive valid readings.
∙ Pulse pressure is the standard average of the differences between systolic and diastolic pressures recorded at the same time.
∙ Blood pressure load is the percentage of blood pressure readings above than normal level.
Unit

Figure 10: Report forwarded by the ARVmobile to specified healthcare providers.

Figure 11: ARVmobile-Android graphic user interface allowing
change of language.

prevalence of hypertension is high [2], more than 50% of
hypertensive individuals are unaware of their condition [89],
and control of hypertension is only around 13.5% [90]. Awareness of isolated systolic hypertension (ISH), which involves
high SBP and normal DBP and is more common in the
elderly [91], is particularly appropriate to the ARVmobile 1.0.
ISH is a major cardiovascular risk factor: each 20/10 mmHg
increase doubles the risk for older hypertensive patients [92].
In older patients with ISH, ABP is a better predictor of
risk than clinical BP measurements [93, 94]. Cardiovascular
death increased 10% and 18%, respectively, for each 10 mm
Hg increase in daytime and nighttime SBP, but the same
increase in clinical SBP was not associated with a significant

mortality increase [93]. The ARVmobile 1.0 presents some of
this information in the language change option (Figure 11).
Use of the ARVmobile 1.0 could help avoid overtreatment of elderly patients with white coat hypertension or
lack of treatment for those with masked hypertension [95].
Both issues are associated with cost effectiveness, as well as
diagnosis and treatment. The cost of hypertension control
based on conventional clinical BP measurements can be up
to four times higher than control based on ABP monitoring
[96], due to unnecessary drug therapy for patients with white
coat hypertension [97, 98]; in addition the cost-benefit ratio
would be expected to increase, as the cost of managing
hypertension rises with increasing rates of diagnosis and
prescribing of new, more expensive antihypertensive [62].
Furthermore, the actual raising trend to increase the development of low-cost medical devices [99], and the constant rise
of physician fees for primary care [100], could also promote
the use of personal ABP monitoring, because in clinical
practice, traditional ABP monitors need to be attached and
detached by skilled medical technologists [101].
The main limitation of usability and adoption of the ARVmobile 1.0 is the ABP sensor design, which must integrate
wearability, accurate measurement, power source miniaturization, low power use in reading biosignals and wireless
transmission, and secure data transference. To deliver truly
personalized health care, the biosensors must be invisible to
the user, avoiding activity restriction or behavior modification [20]. Biosensors should be small and lightweight, which
depends largely on the size and weight of batteries. However,
battery capacity is directly proportional to size [102]. The
gold standard for measuring BP with ABP devices is the
oscillometric method, which requires inflating a cuff around
the arm and requires high power. Development of cuffless
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sensors that use other BP measurement techniques, such as
pulse arrival time [103, 104], but still provide accuracy, is
necessary. Another option would be to integrate the sensor
into nonclothing items that are already worn by patients.
The cost of such novel technology could emerge as the new
limitation.
Future development of the ARVmobile requires defining
the minimum number of ABP readings required to assess
BPV in a reliable or reproducible manner, even with conventional ABP monitors such number is not known [82].
Several studies found that short-term, reading-to-reading
BPV estimated by ABP monitoring had poor reproducibility
compared to ABP level [105–108], which could account for the
rather diverse findings regarding the clinical value of BPV as
a predictor of cardiovascular outcomes. The reproducibility
of ARV could be improved by increasing the number of BP
readings, but 24-hour ABP monitoring can be uncomfortable, especially for elderly patients. Therefore, it is necessary
to determine a minimum range of BP readings to calculate
ARV without significant loss of information, because accurate
calculation of ARV with an adequate number of BP measurements might have great relevance for clinical purposes,
and its final implementation in the ARVmobile 1.0 would
improve the adoption and use of PHM applications for CVDs
prevention. In this sense, the ARVmobile could be a useful
and cost-saving PHM system to perform a detailed profile
of ABP and HR in an ordinary daily life environment and
to estimate potential diagnostic thresholds of abnormal BPV
measured as ARV.
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[102] A. Milenković, C. Otto, and E. Jovanov, “Wireless sensor
networks for personal health monitoring: issues and an implementation,” Computer Communications, vol. 29, no. 13-14, pp.
2521–2533, 2006.
[103] C. C. Y. Poon and Y. T. Zhang, “Cuff-less and noninvasive
measurements of arterial blood pressure by pulse transit time,”
in Proceedings of the 27th Annual International Conference of
the Engineering in Medicine and Biology Society, pp. 5877–5880,
September 2005.
[104] F. S. Cattivelli and H. Garudadri, “Noninvasive cuffless estimation of blood pressure from pulse arrival time and heart rate
with adaptive calibration,” in Proceedings of the 6th International
Workshop on Wearable and Implantable Body Sensor Networks
(BSN ’09), pp. 114–119, Berkeley, Calif, USA, June 2009.
[105] L. Thijs, J. Staessen, R. Fagard, P. Zachariah, and A. Amery,
“Number of measurements required for the analysis of diurnal
blood pressure profile,” Journal of Human Hypertension, vol. 8,
no. 4, pp. 239–244, 1994.
[106] P. Palatini, P. Mormino, C. Canali et al., “Factors affecting ambulatory blood pressure reproducibility: results of the HARVEST
trial,” Hypertension, vol. 23, no. 2, pp. 211–216, 1994.

13
[107] B. Wizner, D. G. Dechering, L. Thijs et al., “Short-term and
long-term repeatability of the morning blood pressure in
older patients with isolated systolic hypertension,” Journal of
Hypertension, vol. 26, no. 7, pp. 1328–1335, 2008.
[108] M. Di Rienzo, G. Grassi, A. Pedotti, and G. Mancia, “Continuous versus intermittent blood pressure measurements in
estimating 24-hour average blood pressure,” Hypertension, vol.
5, no. 2, pp. 264–269, 1983.

MEDIATORS
of

INFLAMMATION

The Scientific
World Journal
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Gastroenterology
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Hindawi Publishing Corporation
http://www.hindawi.com

Diabetes Research
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

International Journal of

Journal of

Endocrinology

Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com

Disease Markers

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Submit your manuscripts at
http://www.hindawi.com
BioMed
Research International

PPAR Research
Hindawi Publishing Corporation
http://www.hindawi.com

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Journal of

Obesity

Journal of

Ophthalmology
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Evidence-Based
Complementary and
Alternative Medicine

Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Oncology
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Parkinson’s
Disease

Computational and
Mathematical Methods
in Medicine
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

AIDS

Behavioural
Neurology
Hindawi Publishing Corporation
http://www.hindawi.com

Research and Treatment
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Oxidative Medicine and
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

